Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Sakane

Showing results (31-40 of 62) with videos related to

Pageof 7
Sort By:
Diabetologia|February 1, 1997
Beta 3-adrenergic-receptor polymorphism: a genetic marker for visceral fat obesity and the insulin resistance syndromeN Sakane, T Yoshida, T Umekawa, et al.
Clinical and Experimental Pharmacology & Physiology|June 1, 1996
Anti-obesity and anti-diabetic effects of mazindol in yellow KK mice: its activating effect on brown adipose tissue thermogenesisT Yoshida, T Umekawa, Y Wakabayashi, et al.
Diabetologia|December 2, 1998
Synergic effect of polymorphisms in uncoupling protein 1 and beta3-adrenergic receptor genes on weight loss in obese JapaneseA Kogure, T Yoshida, N Sakane, et al.
Endocrine Journal|December 1, 1994
Effect of CL 316,243, a novel beta 3-adrenoceptor agonist, on insulin secretion in perfused mouse pancreasT Yoshida, K Yoshioka, N Hiraoka, et al.
European Journal of Endocrinology|April 1, 1997
Anti-obesity and anti-diabetic effects of CL316,243, a highly specific beta 3-adrenoceptor agonist, in Otsuka Long-Evans Tokushima Fatty rats: induction of uncoupling protein and activation of glucose transporter 4 in white fatT Umekawa, T Yoshida, N Sakane, et al.
International Journal of Sports Medicine|August 21, 2012
Accumulation of short bouts of non-exercise daily physical activity is associated with lower visceral fat in Japanese female adultsM Ayabe, H Kumahara, K Morimura, et al.
International Journal of Clinical Pharmacology Research|January 1, 1994
Usefulness of mazindol in combined diet therapy consisting of a low-calorie diet and Optifast in severely obese womenT Yoshida, N Sakane, T Umekawa, et al.
Lancet (London, England)|November 25, 1995
Mutation of beta 3-adrenergic-receptor gene and response to treatment of obesityT Yoshida, N Sakane, T Umekawa, et al.
The Journal of Clinical Endocrinology and Metabolism|January 1, 1996
Growth hormone (GH) secretory dynamics in a case of acromegalic gigantism associated with hyperprolactinemia: nonpulsatile secretion of GH may induce elevated insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 levelsT Yoshida, A Shimatsu, N Sakane, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|May 1, 1994
The alpha/beta-adrenergic receptor blocker arotinolol activates the thermogenesis of brown adipose tissue in monosodium-L-glutamate-induced obese miceT Yoshida, N Sakane, Y Wakabayashi, et al.
Pageof 7

Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
Diabetologia|February 1, 1997
Beta 3-adrenergic-receptor polymorphism: a genetic marker for visceral fat obesity and the insulin resistance syndromeN Sakane, T Yoshida, T Umekawa, et al.
Clinical and Experimental Pharmacology & Physiology|June 1, 1996
Anti-obesity and anti-diabetic effects of mazindol in yellow KK mice: its activating effect on brown adipose tissue thermogenesisT Yoshida, T Umekawa, Y Wakabayashi, et al.
Diabetologia|December 2, 1998
Synergic effect of polymorphisms in uncoupling protein 1 and beta3-adrenergic receptor genes on weight loss in obese JapaneseA Kogure, T Yoshida, N Sakane, et al.
Endocrine Journal|December 1, 1994
Effect of CL 316,243, a novel beta 3-adrenoceptor agonist, on insulin secretion in perfused mouse pancreasT Yoshida, K Yoshioka, N Hiraoka, et al.
European Journal of Endocrinology|April 1, 1997
Anti-obesity and anti-diabetic effects of CL316,243, a highly specific beta 3-adrenoceptor agonist, in Otsuka Long-Evans Tokushima Fatty rats: induction of uncoupling protein and activation of glucose transporter 4 in white fatT Umekawa, T Yoshida, N Sakane, et al.
International Journal of Sports Medicine|August 21, 2012
Accumulation of short bouts of non-exercise daily physical activity is associated with lower visceral fat in Japanese female adultsM Ayabe, H Kumahara, K Morimura, et al.
International Journal of Clinical Pharmacology Research|January 1, 1994
Usefulness of mazindol in combined diet therapy consisting of a low-calorie diet and Optifast in severely obese womenT Yoshida, N Sakane, T Umekawa, et al.
Lancet (London, England)|November 25, 1995
Mutation of beta 3-adrenergic-receptor gene and response to treatment of obesityT Yoshida, N Sakane, T Umekawa, et al.
The Journal of Clinical Endocrinology and Metabolism|January 1, 1996
Growth hormone (GH) secretory dynamics in a case of acromegalic gigantism associated with hyperprolactinemia: nonpulsatile secretion of GH may induce elevated insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 levelsT Yoshida, A Shimatsu, N Sakane, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|May 1, 1994
The alpha/beta-adrenergic receptor blocker arotinolol activates the thermogenesis of brown adipose tissue in monosodium-L-glutamate-induced obese miceT Yoshida, N Sakane, Y Wakabayashi, et al.
Pageof 7